These results indicate that peptides within DEAD box domain of CAGE enhance apoptotic effects of anti-cancer drugs by decreasing the expression of cyclinD1, pGSK3βSer9 and the binding of CAGE to GSK3β. The gene discussed is GSK3B; the disease is cancer.